ArticleCancer medicine2019

Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.

Benelita T Elie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.